PDZK1 directly regulates the function of organic cation/carnitine transporter OCTN2

Yukio Kato1, Yoshimichi Sai, Kazuhiro Yoshida

  • 1Division of Pharmaceutical Sciences, Graduate School of Natural Science and Technology, Kanazawa University, Kakuma, Kanazawa, Ishikawa 920-1192, Japan.

Molecular Pharmacology
|November 4, 2004
PubMed

Insights

The study identifies PDZK1 as a key regulator of organic cation transporter OCTN2, enhancing carnitine uptake in kidney tubules. This interaction, mediated by OCTN2's C-terminus, is crucial for renal transport of cationic substances.

Area of Science:

  • Renal Physiology
  • Molecular Biology
  • Membrane Transport

Background:

  • Organic cation transporters (OCTs and OCTNs) mediate xenobiotic excretion in renal tubules.
  • Mechanisms for targeting OCTs/OCTNs to specific kidney membranes remain unclear.
  • PDZ proteins are implicated in scaffolding and regulating membrane proteins.

Purpose of the Study:

  • To investigate the interaction of OCT and OCTN transporters with PDZ proteins.
  • To elucidate the molecular mechanisms regulating renal transporter localization and function.
  • To identify functional regulators of OCTN2 in kidney brush-border membranes.

Main Methods:

  • Yeast two-hybrid and pull-down assays using recombinant transporter C-termini.
  • Analysis of transporter interaction with PDZK1 and NHERF2.
  • Immunohistochemistry and surface protein biotinylation in kidney cells.
  • Functional uptake assays of carnitine using transfected cells.

Main Results:

  • OCTN1 and OCTN2, but not OCT1 or OCT2, specifically interact with PDZK1 and NHERF2.
  • The C-terminal four amino acids of OCTN1 and OCTN2 are essential for PDZK1 interaction.
  • PDZK1 and OCTN2 colocalize in kidney brush-border membranes.
  • PDZK1 significantly enhances OCTN2-mediated carnitine uptake by increasing transport capacity, not surface expression.

Conclusions:

  • PDZK1 directly interacts with the C terminus of OCTN2, regulating its function.
  • This interaction is critical for the enhanced transport capacity of OCTN2 in renal brush-border membranes.
  • PDZK1 acts as a functional regulator of OCTN2, impacting renal excretion of cationic substrates.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
The ADP/ATP Carrier Protein01:42

The ADP/ATP Carrier Protein

ADP/ATP carrier or AAC protein is the most abundant carrier protein in the inner mitochondrial membrane. It transports large quantities of ADP and ATP, equivalent to the average human body weight, every day. Among other transporters, ACC protein is one of the best-studied members of the mitochondrial carrier protein family. The ADP/ATP carrier protein comprises two transmembrane helices connected to a loop and a single alpha-helix on the matrix side. It switches between two conformational...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...